Breaking News

Fujifilm Diosynth Biotech Adds SUBioreactor

Fujifilm Diosynth Biotechnologies is expanding its manufacturing capabilities with the addition of a 1,000L Xcellerex Single-Use Bioreactor at its RTP, NC facility.

Fujifilm Diosynth Biotechnologies is expanding its manufacturing capabilities with the addition of a 1,000L Xcellerex Single-Use Bioreactor at its RTP, NC facility. The bioreactor, single-use mixers and single-use harvest filtration will supplement existing seed train and purification equipment as part of a hybrid implementation approach. This project represents the company’s continuation of cell culture capacity expansion and is anticipated to be validated and fully operational by 1Q12.
 
“Single-use technologies are uniquely suited for multi-product contract manufacturing with the added advantage that the operations are easily transferable between sites and are easily expandable for increased supply needs,” said Stephen Spearman, president of Fujifilm Diosynth Biotechnologies USA.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters